Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans

Hirohisa Takano, Naomi Osakabe, Chiaki Sanbongi, Rie Yanagisawa, Ken Ichiro Inoue, Akiko Yasuda, Midori Natsume, Seigo Baba, Ei Ichiro Ichiishi, Toshikazu Yoshikawa

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, age-matched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n = 10] or 50 mg [n = 9]) or placebo (n = 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1β, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalExperimental Biology and Medicine
Volume229
Issue number3
Publication statusPublished - 2004 Mar
Externally publishedYes

    Fingerprint

Keywords

  • Alternative medicine
  • Extract of Perilla frutescens
  • Polymorphonuclear leukocytes
  • Randomized, double-blind, age-matched, placebo-controlled parallel group study
  • Rosmarinic acid
  • Seasonal allergic rhinoconjunctivitis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Takano, H., Osakabe, N., Sanbongi, C., Yanagisawa, R., Inoue, K. I., Yasuda, A., Natsume, M., Baba, S., Ichiishi, E. I., & Yoshikawa, T. (2004). Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans. Experimental Biology and Medicine, 229(3), 247-254.